179 related articles for article (PubMed ID: 28327378)
1. Gender-related psychopathology in opioid use disorder: Results from a representative sample of Italian addiction services.
Leone B; Di Nicola M; Moccia L; Pettorruso M; De Risio L; Nucara G; Zamboni L; Callea A; Janiri L; Cibin M; Lugoboni F;
Addict Behav; 2017 Aug; 71():107-110. PubMed ID: 28327378
[TBL] [Abstract][Full Text] [Related]
2. Interrelationship of Opioid Dependence, Impaired Impulse Control, and Depressive Symptoms: An Open-Label Cross-Sectional Study of Patients in Maintenance Therapy.
Peters L; Soyka M
Neuropsychobiology; 2019; 77(2):73-82. PubMed ID: 30453290
[TBL] [Abstract][Full Text] [Related]
3. Frequency and correlates of sleep disturbance in methadone and buprenorphine-maintained patients.
Dunn KE; Finan PH; Andrew Tompkins D; Strain EC
Addict Behav; 2018 Jan; 76():8-14. PubMed ID: 28735039
[TBL] [Abstract][Full Text] [Related]
4. Constipation and other common symptoms reported by women and men in methadone and buprenorphine maintenance treatment.
Haber PS; Elsayed M; Espinoza D; Lintzeris N; Veillard AS; Hallinan R
Drug Alcohol Depend; 2017 Dec; 181():132-139. PubMed ID: 29054032
[TBL] [Abstract][Full Text] [Related]
5. The association between age of onset of opioid use and comorbidity among opioid dependent patients receiving methadone maintenance therapy.
Naji L; Dennis BB; Bawor M; Varenbut M; Daiter J; Plater C; Pare G; Marsh DC; Worster A; Desai D; MacKillop J; Thabane L; Samaan Z
Addict Sci Clin Pract; 2017 Mar; 12(1):9. PubMed ID: 28347350
[TBL] [Abstract][Full Text] [Related]
6. Co-morbid pain and opioid addiction: long term effect of opioid maintenance on acute pain.
Wachholtz A; Gonzalez G
Drug Alcohol Depend; 2014 Dec; 145():143-9. PubMed ID: 25456326
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of the Brief Pain Inventory in Patients with Opioid Addiction Receiving Methadone Maintenance Treatment.
Dennis BB; Roshanov PS; Bawor M; Paul J; Varenbut M; Daiter J; Plater C; Pare G; Marsh DC; Worster A; Desai D; Thabane L; Samaan Z
Pain Physician; 2016 Jan; 19(1):E181-95. PubMed ID: 26752486
[TBL] [Abstract][Full Text] [Related]
8. Influence of attention deficit hyperactivity disorder and conduct disorder on opioid dependence severity and psychiatric comorbidity in chronic methadone-maintained patients.
Carpentier PJ; van Gogh MT; Knapen LJ; Buitelaar JK; De Jong CA
Eur Addict Res; 2011; 17(1):10-20. PubMed ID: 20881401
[TBL] [Abstract][Full Text] [Related]
9. Association between cannabis use and methadone maintenance treatment outcomes: an investigation into sex differences.
Zielinski L; Bhatt M; Sanger N; Plater C; Worster A; Varenbut M; Daiter J; Pare G; Marsh DC; Desai D; MacKillop J; Steiner M; McDermid Vaz S; Thabane L; Samaan Z
Biol Sex Differ; 2017; 8():8. PubMed ID: 28367308
[TBL] [Abstract][Full Text] [Related]
10. Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus.
Dematteis M; Auriacombe M; D'Agnone O; Somaini L; Szerman N; Littlewood R; Alam F; Alho H; Benyamina A; Bobes J; Daulouede JP; Leonardi C; Maremmani I; Torrens M; Walcher S; Soyka M
Expert Opin Pharmacother; 2017 Dec; 18(18):1987-1999. PubMed ID: 29183228
[TBL] [Abstract][Full Text] [Related]
11. Long-acting intramuscular naltrexone for opioid use disorder: Utilization and association with multi-morbidity nationally in the Veterans Health Administration.
Kelly MM; Reilly E; Quiñones T; Desai N; Rosenheck R
Drug Alcohol Depend; 2018 Feb; 183():111-117. PubMed ID: 29245103
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of constipation and reduced quality of life in opioid-dependent patients treated with opioid substitution treatments.
Lugoboni F; Mirijello A; Zamboni L; Faccini M; Casari R; Cossari A; Gasbarrini A; Addolorato G; On Behalf Of Gics
Expert Opin Pharmacother; 2016 Nov; 17(16):2135-2141. PubMed ID: 27603712
[TBL] [Abstract][Full Text] [Related]
13. Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study.
Kenworthy J; Yi Y; Wright A; Brown J; Maria Madrigal A; Dunlop WCN
J Med Econ; 2017 Jul; 20(7):740-748. PubMed ID: 28489467
[TBL] [Abstract][Full Text] [Related]
14. Treatment Outcomes Among Black Adults Receiving Medication for Opioid Use Disorder.
Parlier-Ahmad AB; Pugh M; Martin CE
J Racial Ethn Health Disparities; 2022 Aug; 9(4):1557-1567. PubMed ID: 34254271
[TBL] [Abstract][Full Text] [Related]
15. Psychiatric comorbidity among patients on methadone maintenance therapy and its influence on quality of life.
Teoh Bing Fei J; Yee A; Habil MH
Am J Addict; 2016 Jan; 25(1):49-55. PubMed ID: 26692463
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with buprenorphine versus methadone use in pregnancy.
Krans EE; Bogen D; Richardson G; Park SY; Dunn SL; Day N
Subst Abus; 2016; 37(4):550-557. PubMed ID: 26914546
[TBL] [Abstract][Full Text] [Related]
17. A latent class analysis of self-reported clinical indicators of psychosocial stability and adherence among opioid substitution therapy patients: do stable patients receive more unsupervised doses?
Larance B; Carragher N; Mattick RP; Lintzeris N; Ali R; Degenhardt L
Drug Alcohol Depend; 2014 Sep; 142():46-55. PubMed ID: 25015687
[TBL] [Abstract][Full Text] [Related]
18. Past-year gambling behaviour among patients receiving opioid substitution treatment.
Castrén S; Salonen AH; Alho H; Lahti T; Simojoki K
Subst Abuse Treat Prev Policy; 2015 Jan; 10():4. PubMed ID: 25626451
[TBL] [Abstract][Full Text] [Related]
19. Managing psychiatric comorbidity within versus outside of methadone treatment settings: a randomized and controlled evaluation.
Brooner RK; Kidorf MS; King VL; Peirce J; Neufeld K; Stoller K; Kolodner K
Addiction; 2013 Nov; 108(11):1942-51. PubMed ID: 23734943
[TBL] [Abstract][Full Text] [Related]
20. Use and misuse of opioid agonists in opioid addiction.
Modesto-Lowe V; Swiezbin K; Chaplin M; Hoefer G
Cleve Clin J Med; 2017 May; 84(5):377-384. PubMed ID: 28530896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
